Beijing to begin COVID-19 vaccination among key groups

0 Comment(s)Print E-mail Xinhua, January 1, 2021
Adjust font size:
A staff member tests samples of the COVID-19 inactivated vaccine at a vaccine production base of the Beijing Biological Products Institute Co., Ltd. in Beijing, capital of China, April 11, 2020. [Photo/Xinhua]

Beijing will start administering COVID-19 vaccines among specific groups of people with higher infection risks, the municipal health authorities said on Thursday.

Nine groups of people aged 18 to 59 will receive the vaccine before the Spring Festival of 2021, which falls on Feb. 12. These include frontline customs inspectors of imported cold-chain goods and personnel working in the overseas and domestic transportation sector. So said Gao Xiaojun, spokesperson for the municipal health commission, at a press briefing.

After the vaccines get market approval, authorities in Beijing will start vaccination for other groups on a reservation basis, said Gao.

China announced on Thursday that it had granted conditional marketing authorization for its first self-developed COVID-19 vaccine.

The inactivated vaccine got approval from the National Medical Products Administration (NMPA). It was developed by the Beijing Biological Products Institute Co., Ltd. under the China National Biotec Group (CNBG), affiliated with Sinopharm.

Follow China.org.cn on Twitter and Facebook to join the conversation.
ChinaNews App Download
Print E-mail Bookmark and Share

Go to Forum >>0 Comment(s)

No comments.

Add your comments...

  • User Name Required
  • Your Comment
  • Enter the words you see:    
    Racist, abusive and off-topic comments may be removed by the moderator.
Send your storiesGet more from China.org.cnMobileRSSNewsletter